Quantonation

Founded in 2018, Quantonation is a Paris-based venture capital firm focused on investing in deep physics, molecular design, high-performance calculation, cybersecurity, ultra-precise sensing, and quantum technologies. The company aims to support the transition of these innovative technologies into commercially available products for industry.

Zoe Amblard Ph.D

Principal

Jean-Gabriel Boinot-Tramoni

Principal at Quantonation 1

Thierry Botter Ph.D

Venture Partner

Simone Planté

Venture Partner

Olivier Tonneau

Co-Founder and Partner

Past deals in Paris

Resolve Stroke

Seed Round in 2023
Resolve Stroke, headquartered in Paris, is a HealthTech company dedicated to revolutionizing medical imaging. It specializes in enhancing ultrasound technology to extract more detailed information, enabling advanced diagnostics, particularly in neurology. The company's innovative software engines improve ultrasound contrast, resolution, and penetration depth, allowing for the visualization of micro-vessels through the human skull in 3D. With a global focus, Resolve Stroke aims to accelerate treatments for over 1 billion people affected by brain diseases. To date, it has secured €3 million in pre-seed funding to pioneer software-based ultrasound innovation.

Qubit Pharmaceuticals

Seed Round in 2022
Qubit Pharmaceuticals is a Paris-based drug discovery company established in 2020. It develops a simulation platform that reduces the cost and duration of preclinical development by using proprietary force field models and molecular dynamics to perform virtual screening and visualization, enabling the identification of viable drug candidates. The platform applies quantum physics-inspired modeling to support biopharmaceutical research and aims to translate advanced computational methods into practical tools for drug development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.